Skip to main content
    C

    CVRx Inc (CVRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.61
    -0.00 (-0.33%)

    Market Cap: $17.30M

    Last updated: Nov 17, 2026 at 4:19 PM ET

    CVRx Inc (CVRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    CVRX has a market cap of $17.30M and an enterprise value of $17.21M. It kept -88.28% of revenue as net income over the last 12 months. Its share count is up 4.12% from a year earlier.

    Total Valuation

    Enterprise value is 0.53% below the market cap, as cash exceeds debt.

    Market Cap$17.30M
    Enterprise Value$17.21M
    Latest price (Nov 17, 2026)$0.61

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.76% in the quarter ended Sep 30, 2026 and grew 9.36% a year over 2 years.

    Shares Outstanding27.25M
    Shares Change (YoY)+4.12%
    Shares Change (QoQ)+2.76%
    Share Count Growth (2Y CAGR)+9.36%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 1.2x. Its year-end P/S ranged from 0.7x to 16.8x from 2021 to 2025.

    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio1.2x

    Valuation history and multiples

    Price Statistics

    The stock is down 93.41% over 52 weeks and trades 65.34% below its 50-day average.

    Beta (1Y)0.70
    52-Week Change-93.41%
    1-Month Change-54.74%
    3-Month Change-78.33%
    6-Month Change-89.83%
    5-Year Change-91.66%
    Total Return (1Y)-93.41%
    Total Return (3Y CAGR)-67.43%
    Total Return (5Y CAGR)-46.82%
    Max Drawdown (1Y)-93.92%
    Max Drawdown (3Y)-98.16%
    Sharpe Ratio (1Y)-1.95
    Correlation with SPY (1Y)0.07
    50-Day Average$1.76
    200-Day Average$4.94
    52-Week Range$0.57 to $10.28
    RSI (14 Days)21.2
    Average Volume (20 Days)843.76K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.80x current liabilities, and total debt is 4.24x shareholder equity.

    Current Ratio6.80x
    Quick Ratio5.71x
    Debt / Equity4.24x
    Interest Coverage-7.66x

    Returns and Efficiency

    Return on invested capital is -65.00% over the last 12 months, against a 5-year average of -53.45%.

    Return on Equity (ROE)-385.45%
    Return on Assets (ROA)-60.79%
    Return on Invested Capital (ROIC)-65.00%
    Return on Capital Employed (ROCE)-62.73%
    ROE (5Y Average)-68.33%
    ROA (5Y Average)-38.59%
    ROIC (5Y Average)-53.45%
    Asset Turnover0.61x
    Inventory Turnover0.59x
    Receivables Turnover6.35x
    Cash Conversion Cycle488 days

    Scores

    CVRX has an Altman Z-Score of -10.06, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-10.06
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $60.33M over the last 12 months is up 7.79% from the 12 months before.

    Revenue$60.33M
    Revenue Growth (YoY)+7.79%
    Gross Profit$52.43M
    Operating Income-$49.41M
    Pretax Income-$53.27M
    Net Income-$53.26M
    EBITDA-$45.98M
    EBIT-$47.11M
    Reported EPS (TTM)-$2.01

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 15.77% of the $87.61M in total assets.

    Cash and Equivalents$58.75M
    Total Debt$58.66M
    Net Cash$91.00K
    Net Cash Per Share$0.00
    Working Capital$72.51M
    Shareholder Equity$13.82M
    Book Value Per Share$0.51
    Total Assets$87.61M
    Total Liabilities$73.79M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $400.00K of capital spending, operating cash flow left -$42.05M of free cash flow.

    Operating Cash Flow-$41.65M
    Capital Expenditures$400.00K
    Free Cash Flow-$42.05M
    FCF Per Share-$1.58
    Depreciation and Amortization$1.13M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -81.90%.

    Gross Margin86.90%
    Operating Margin-81.90%
    Pretax Margin-88.29%
    Net Margin-88.28%
    EBITDA Margin-76.21%
    EBIT Margin-78.09%
    FCF Margin-69.69%
    Gross Margin (5Y Average)80.60%

    Growth

    Revenue grew 36.11% a year over 3 years.

    Revenue Growth (3Y CAGR)+36.11%
    Revenue Growth (5Y CAGR)+56.40%
    Book Value Per Share Growth (2Y CAGR)-35.87%
    Tangible Book Per Share Growth (2Y CAGR)-35.87%

    Revenue and profit by year

    Dividends and Yields

    CVRX does not pay a dividend. Its free cash flow yield is -252.56%.

    FCF Yield-252.56%
    Buyback Yield-39.14%
    Shareholder Yield-39.14%

    Peer Position

    Against 10 similar companies, CVRX has the 10th highest P/S and the 4th highest ROIC.

    P/S Ratio0.3x vs 1.6x median
    ROIC-65.00% vs -137.49% median
    Revenue Growth (Trailing 4 Quarters, YoY)+7.79% vs +11.65% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 1.28% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+1.28%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CVRX

    What is CVRX's market cap?

    CVRX has a market cap of $17.30M. Its enterprise value, which adds debt and subtracts cash, is $17.21M.

    How many shares of CVRX are outstanding?

    CVRX has 27.25M shares outstanding. The count is up 4.12% from a year earlier.

    Does CVRX pay a dividend?

    No. CVRX does not pay a dividend.

    How much debt does CVRX have?

    CVRX has $58.66M of total debt and $58.75M of cash and equivalents, a net cash position of $91.00K.